Top Losers: StemCells (NASDAQ:STEM), CytRx (NASDAQ:CYTR), Neonode (NASDAQ:NEON), Halcon Resources (NYSE:HK), Yamana Gold (NYSE:AUY)

Research analysts at Maxim Group lifted their price target on shares of Stemcells Inc (NASDAQ:STEM) from $2.50 to $5.00 in a report released on Friday. The firm currently has a “buy” rating on the stock. Maxim Group’s price objective indicates a potential upside of 155.10% from the company’s current price. StemCells Inc (NASDAQ:STEM) stock performance was -6.12% in last session and finished the day at … Continue reading Top Losers: StemCells (NASDAQ:STEM), CytRx (NASDAQ:CYTR), Neonode (NASDAQ:NEON), Halcon Resources (NYSE:HK), Yamana Gold (NYSE:AUY)

Biotech Volatile Movements: CEL-SCI (NYSEMKT:CVM), NewLink Genetics (NASDAQ:NLNK), Alder Biopharmaceuticals (NASDAQ:ALDR), CytRx (NASDAQ:CYTR), StemCells Inc (NASDAQ:STEM)

CEL-SCI Corporation (NYSEMKT:CVM) announced that Geert Kersten Chief Executive Officer will be presenting at the 2014 BIO International Convention on Wednesday June 25th at 2:00 p.m. PDT. Hosted by the Biotechnology Industry Organization (BIO) this year’s global event for biotechnology will take place June 23-26 at the San Diego Convention Center in San Diego California. CEL-SCI Corporation (NYSEMKT:CVM) stock performance was -6.40% in last session … Continue reading Biotech Volatile Movements: CEL-SCI (NYSEMKT:CVM), NewLink Genetics (NASDAQ:NLNK), Alder Biopharmaceuticals (NASDAQ:ALDR), CytRx (NASDAQ:CYTR), StemCells Inc (NASDAQ:STEM)

DARA Biosciences Inc (NASDAQ:DARA) on May 15 announced its support for Neuropathy Awareness Week which is being observed during the week of May 12, 2014 and sponsored in the U.S. by The Neuropathy Association (www.neuropathy.org). DARA Biosciences Inc (NASDAQ:DARA) stock performance was -26.61% in last session and finished the day at $1.60. Traded volume was 4.15million shares in the last session and the average volume … Continue reading Biotech Volatile Stocks: DARA Biosciences Inc (NASDAQ:DARA), Concert Pharmaceuticals Inc (NASDAQ:CNCE), Prosensa Holding NV (NASDAQ:RNA), CytRx Corporation (NASDAQ:CYTR)

ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) presented results from a global, multi-center, open-label, comparator-controlled phase II study in patients undergoing total knee replacement surgery or total knee arthroplasty (TKA). Two doses of ISIS-FXIRx (200mg, 300mg) were compared to Sanofi’s Lovenox (enoxaparin). ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) stock performance was 11.26% in last session and finished the day at $27.81. Traded volume was 4,554,523 shares in the last session … Continue reading Notable Movers: ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS), PTC Therapeutics, Inc. (NASDAQ:PTCT), Orexigen Therapeutics, Inc. (NASDAQ:OREX), CytRx Corporation (NASDAQ:CYTR), ZIOPHARM Oncology (NASDAQ:ZIOP)

CytRx Corporation (NASDAQ:CYTR) seeks to present the detailed results of the positive outcome from the study which was conducted in an animal representation of glioblastoma at the AACRAM which will be held from between April 5 and April 9 in San Diego, CA. CytRx Corporation (NASDAQ:CYTR) stock performance was 3.67% in last session and finished the day at $3.95. Traded volume was 11.77million shares in … Continue reading Micro-cap Active runners: CytRx Corporation (NASDAQ:CYTR), Response Genetics (NASDAQ:RGDX), Catalyst Pharmaceutical Partners (NASDAQ:CPRX), Rexahn Pharmaceuticals (NYSEMKT:RNN)

MannKind Corporation (NASDAQ:MNKD) had its price objective reduced by Cowen and Company from $5.50 to $5.00 in a report released on Wednesday,Stock Ratings News reports. Analysts at Piper Jaffray downgraded shares of MannKind Corporation (NASDAQ:MNKD) from a neutral rating to an underweight rating in a research note on Monday. MannKind Corporation (NASDAQ:MNKD) stock performance was -0.86% in last session and finished the day at $6.93. … Continue reading Biotech Runners: MannKind Corporation (NASDAQ:MNKD), Gilead Sciences (NASDAQ:GILD), Ariad Pharmaceuticals (NASDAQ:ARIA), CytRx Corporation (NASDAQ:CYTR)